YOLFTbeta
LS

CK Life Sciences Int'l. (Holdings) Inc

LSI · F · Healthcare / Biotechnology

0.06EUR-0.00 (-0.83%)

Price History

Full chart

Market Stats

Previous Close0.0605
Open0.06
Day Range0.06 – 0.06
52-Week Range0.0575 – 0.11
Volume0
Market Cap567.05M
P/E (TTM)0.00
Forward P/E23.15
EPS0.00
Dividend Yield0.00%
Beta0.46
50-Day Avg0.0611
200-Day Avg0.0744

About

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, trades, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines; supplies raw materials in nutritional health, pharmaceutical, cosmetics, personal care and food segments; financing activities; holding land and buildings; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, the company distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; and produces, refines, and distributes salt products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; develops novel nonopioid therapeutics; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food sectors; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Ying Choi Yu MBA
  • Employees1.93K
  • Headquarters2 Dai Fu Street, Tai Po, Hong Kong, Germany
  • Websitehttps://www.ck-lifesciences.com

Leadership

  • Mr. Tzar Kuoi Li B.Sc., LLD, LLD (Hon), M.Sc.Executive Chairman · b. 1964
  • Mr. Ying Choi Yu MBACEO & Executive Deputy Chairman · b. 1956
  • Mr. Hing Lam Kam B.Sc., B.ScE, M.B.A.President & Executive Director · b. 1946
  • Mr. Tak Chuen IP B.A., M.Sc.Senior VP, Chief Investment Officer & Executive Director · b. 1952
  • Dr. Kean Meng Toh M.D., MBBSVP, Chief Scientific Officer & Executive Director · b. 1967
  • Mr. Wun Lam WongChief Financial Officer · b. 1965
  • Ms. Emily TanChief Operating Officer
  • Ms. Yau Lin WongGeneral Manager of Human Resources & Administration · b. 1967
  • Ms. Ching Sze ChiuGeneral Counsel · b. 1977
  • Ms. Sze Mun HoVice President of Corporate Development · b. 1972

Financials

Income Statement

Currency: HKD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.97B4.95B4.92B4.87B4.69B5.23B4.97B4.94B5.40B5.28B5.32B5.52B5.41B
Growth (%)--0.34%-0.70%-1.03%-3.60%+11.50%-5.08%-0.49%+9.30%-2.35%+0.89%+3.76%-2.04%
Cost of Revenue3.23B3.21B3.18B3.21B3.15B3.50B3.36B3.54B3.77B3.65B3.69B3.83B3.83B
Gross Profit1.74B1.74B1.74B1.66B1.54B1.73B1.61B1.41B1.63B1.63B1.64B1.69B1.58B
Gross Margin35.04%35.13%35.41%34.12%32.90%33.14%32.35%28.47%30.17%30.82%30.76%30.65%29.15%
Operating Expense1.42B1.43B1.46B592.01M586.66M584.61M650.04M647.79M685.85M1.38B1.41B1.62B1.71B
Operating Income320.98M310.43M278.68M1.07B957.15M1.15B956.70M759.11M944.12M242.09M223.85M77.46M-131.03M
Operating Margin6.46%6.27%5.66%21.96%20.39%21.97%19.26%15.36%17.48%4.59%4.21%1.40%-2.42%
EBITDA----569.07M689.19M580.73M355.10M450.35M598.87M624.75M490.86M494.20M
EBITDA Margin----12.13%13.17%11.69%7.18%8.34%11.35%11.74%8.89%9.13%
Net Income229.01M263.56M218.86M251.97M258.40M263.00M181.74M125.23M162.80M131.96M17.25M-126.55M-186.81M
Net Income Margin4.61%5.32%4.45%5.18%5.51%5.03%3.66%2.53%3.01%2.50%0.32%-2.29%-3.45%
Interest Expense00000129.67M158.88M128.73M97.82M163.09M322.43M337.18M266.89M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%2.48%3.20%2.60%1.81%3.09%6.06%6.11%4.93%

Balance Sheet

Currency: HKD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10.22B10.30B9.51B9.54B10.58B10.44B10.71B11.98B11.73B11.27B11.25B10.79B11.84B
Total Liabilities5.02B5.42B5.25B5.08B5.83B6.02B6.54B7.26B7.23B7.11B7.06B7.28B7.99B
Total Equity4.98B4.66B4.12B4.31B4.62B4.26B4.18B4.72B4.50B4.16B4.19B3.51B3.78B
Cash767.66M979.20M840.75M859.43M1.04B773.37M696.50M959.00M890.80M691.93M664.32M553.97M603.07M
Net Debt----3.56B4.04B4.41B4.64B4.75B4.74B4.76B4.92B5.43B

Cash Flow

Currency: HKD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow267.06M324.52M303.71M438.91M134.57M230.69M379.15M530.96M423.57M363.66M514.18M353.53M186.95M
Investing Cash Flow-1.26B-414.04M-130.47M-26.79M-112.25M-373.89M-253.92M-457.31M-257.88M----
Financing Cash Flow1.24B283.19M-291.03M-366.75M138.09M-97.75M-192.21M168.74M-220.08M----
Capital Expenditure187.44M279.19M212.26M210.05M92.03M194.05M163.96M335.44M216.20M216.97M291.83M199.47M247.93M
Free Cash Flow----40.11M-57.11M181.37M151.12M206.33M146.69M222.35M154.06M-60.98M
Dividends Paid57.67M67.28M76.89M86.50M96.11M96.11M96.11M96.11M96.11M96.11M76.89M--
FCF to OCF----29.80%-24.75%47.84%28.46%48.71%40.34%43.24%43.58%-32.62%
Dividend Paid to FCF----239.64%-168.30%52.99%63.60%46.58%65.52%34.58%--

Earnings

Report DateJun 30, 2018
EPS Estimate-
EPS Actual0.85
Surprise-
Timing-

Key Statistics & Ratios

Market Cap567.05M
Enterprise Value1.30B
Trailing P/E0.00
Forward P/E23.15
PEG Ratio0.00
Price / Sales0.10
Price / Book1.31
EPS0.00
Book Value0.0456
Revenue (TTM)5.52B
Gross Profit (TTM)1.55B
EBITDA152.94M
Profit Margin-1.17%
Operating Margin3.17%
Return on Equity-2.23%
Return on Assets-0.06%
Shares Outstanding9.61B
Shares Float2.40B
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.00May 23, 2023
20221×
0.00May 20, 2022
20211×
0.00May 18, 2021
20201×
0.00May 19, 2020
20191×
0.00May 21, 2019
20181×
0.00May 15, 2018
20171×
0.00May 16, 2017
20161×
0.00May 18, 2016
20151×
0.00May 20, 2015
20141×
0.00May 20, 2014
20131×
0.00May 23, 2013
20121×
0.00May 29, 2012
20111×
0.00May 9, 2011